Sutter Medical Center Sacramento — Sacramento, California

Public research footprint of Sutter Medical Center Sacramento, compiled from the ClinicalTrials.gov public registry.

266

Registered studies

146

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Recurrent Platinum-Resistant Fallopian Tube Carcinoma · Recurrent Platinum-Resistant Primary Peritoneal Carcinoma · Recurrent Platinum-Resistant Ovarian Carcinoma · Ovarian Seromucinous Carcinoma

Recently updated registry entries

NCT03258554 — Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally… (Completed)
NCT04739800 — Comparison of Standard of Care Treatment With a Triplet Combination of Targeted… (Active Not Recruiting)
NCT04267848 — Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Sutter Medical Center Sacramento?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.